Quipt Home Medical (QIPT) – Analysts’ Recent Ratings Updates

Quipt Home Medical (NASDAQ: QIPT) has recently received a number of price target changes and ratings updates:

• 12/22/2025 – Quipt Home Medical had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/17/2025 – Quipt Home Medical was given a new $3.65 price target on by analysts at Canaccord Genuity Group Inc..
• 12/17/2025 – Quipt Home Medical had its price target raised by analysts at Canaccord Genuity Group Inc. from $2.30 to $3.65. They now have a “hold” rating on the stock.
• 12/16/2025 – Quipt Home Medical had its “buy” rating reaffirmed by analysts at Benchmark Co..
• 12/15/2025 – Quipt Home Medical was downgraded by analysts at Stifel Canada from a “strong-buy” rating to a “strong sell” rating.

Quipt Home Medical (NASDAQ: QIPT) is a U.S.-based provider of home medical equipment and related services, specializing in respiratory care and sleep therapy. The company offers a comprehensive range of durable medical equipment (DME) designed to support patients with chronic respiratory conditions, sleep apnea and other pulmonary disorders in the comfort of their own homes.

Key product offerings include continuous positive airway pressure (CPAP) and bilevel devices, oxygen concentrators, noninvasive ventilators, masks, tubing and disposables.